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In the United States, the primary legal frame-
work for managing industrial chemicals 
used in processes and products, the Toxic 
Substances Control Act (TSCA 1976), is now 
over 30 years old and is widely recognized as 
having failed to meet the intent of Congress. 
Analyses of TSCA by the National Research 
Council (NRC 1984), U.S. Government 
Accountability Office (U.S. GAO 1994, 
2005a, 2007, 2009), Congressional Office 
of Technology Assessment (OTA 1995), 
U.S Environmental Protection Agency (U.S. 
EPA 1998, 2003), Environmental Defense 
Fund (Denison 2009; Roe et al. 1997), and 
a former U.S. EPA assistant administrator 
(Goldman 2002) have concluded that the 
statute has all but prevented government, 
businesses, and the public from a) assess-
ing the hazard traits of the great majority of 
chemicals in commerce; b) controlling chemi-
cals of significant concern; and c) motivating 
broad industry investment in cleaner chemi-
cal technologies and safer alternatives, known 
collectively as green chemistry. 
These outcomes are the consequence of 
weaknesses in TSCA that have produced three 
overarching gaps in the U.S. chemicals policy 
(Figure 1) (Wilson et al. 2006, 2008): 
•	Data	gap:	Producers	are	not	required	
to investigate and disclose sufficient 
information on the hazard traits of chemi-
cals to government, the public, or businesses 
that use chemicals.
•	Safety	gap:	Government	lacks	the	legal	tools	
it needs to efficiently identify, prioritize, 
and take action to mitigate the potential 
health and environmental effects of hazard-
ous chemicals.
•	Technology	gap:	Industry	and	govern-
ment have invested only marginally in 
green chemistry research, development, and 
  education. 
Over the last 30 years, the three gaps have 
given rise to a U.S. chemicals market that 
undervalues the safety of chemicals relative 
to their function, price, and performance. 
Chemicals and products are bought and sold 
primarily on the basis of how much work 
they perform per unit cost, with very little 
attention given in the market to their poten-
tial impacts on human health and ecosystems 
throughout the chemical lifecycle. Hazardous 
chemicals have thus remained competitive, 
and broad industrial investment in green 
chemistry has lagged, despite efforts of some 
leading companies. Reflecting these market 
conditions, the nation’s research and educa-
tion agendas have neither prioritized green 
chemistry development nor adequately pre-
pared the next generation of scientists to lead 
the chemical enterprise toward sustainability. 
Collectively, the three gaps—and the market 
conditions they have engendered—present a 
formidable barrier to the scientific, technical, 
and commercial success of green chemistry in 
the United States.
Facing a similar set of chemical manage-
ment problems—and their consequences for 
human health and the environment—the 
European Union in 2006 enacted a sweep-
ing new chemicals regulation known as the 
Registration, Evaluation, Authorisation 
and Restriction of Chemicals (REACH)   
(European Commission 2008; REACH 
2007; U.S. Department of Commerce 2008). 
REACH responds to the barriers described by 
the data gap and safety gap by requiring pro-
ducers to disclose some hazard and exposure 
information on an estimated 30,000 industrial 
chemicals. Chemical manufacturers must also 
gain government authorization to use certain 
“substances of very high concern.” These new 
requirements—both for data and for proving 
safe use—are expected to promote the devel-
opment and use of safer chemical substances, 
closing the technology gap by fueling new 
investment in green chemistry science, tech-
nology, and education (Black 2008; Buckland 
2008; Henzelmann et al. 2007).
Because REACH applies equally in most 
aspects to manufacturers in the European 
Union and foreign importers, it is forc-
ing change among chemical and product 
manufacturers far beyond Europe’s borders 
(Schapiro 2007). Manufacturers worldwide 
cannot afford the losses in market share that 
would result should they fail to comply with 
REACH.
As U.S. producers prepare hazard and 
exposure information for the European Union 
Chemicals Agency (ECHA), the United States 
has a unique opportunity both to make use 
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of the data and to revisit its own chemicals 
policy. In doing so, the United States should 
consider a portfolio of measures that simulta-
neously close the data, safety, and technology 
gaps. This approach will most effectively—
and with minimal delay—instill within the 
chemicals market a more appropriate set of 
incentives and disincentives that are a pre-
condition to motivating broad investment in 
green chemistry.
As with REACH in the European Union, 
a new chemicals policy in the United States 
has the potential to fuel global demand for 
safer substances and processes, increasing the 
incentive for research and development in 
green chemistry while improving human and 
environmental health. It also could move the 
United States into a position of greater collabo-
ration in international sustainability efforts 
and position the country as a global leader in 
green chemistry innovation. Environmental 
health scientists have an essential role in iden-
tifying and addressing the research questions 
that will arise with the development of a new 
U.S. chemicals policy.
Background
A key industry. Over the last 150 years, the 
U.S. chemical industry has contributed sig-
nificantly to both the national and global 
economy (Aftalion 2001; Arora et al. 1998). 
The industry’s contributions to economic 
growth, employment, and improvements in 
life expectancy, health, and living conditions 
in Western-style societies are widely recog-
nized (NRC 1992; Spitz 2003). The indus-
try’s products are ubiquitous; in roughly the 
last 50 years, synthetic chemicals have become 
integrated into nearly all industrial processes 
and commercial products and now constitute 
the primary material base of society (Geiser 
2001). 
The scale of chemical production is corre-
spondingly enormous: Data from the TSCA 
Inventory Update Rule (IUR) show that the 
United States produced or imported about 
15 trillion pounds of chemical substances 
during the 2002 reporting cycle, or about 
42 billion pounds per day (U.S. EPA 2005). 
For the 2005 reporting period, chemical 
manufacturers reported producing or import-
ing about 27 trillion pounds of 6,200 chemi-
cals at more than 25,000 pounds per site per 
year, or about 74 billion pounds per day. 
The IUR data include substances used in 
industrial processes and products and do not 
include fuels, pesticide products, pharma-
ceuticals, or food products. There is no clear 
explanation for the 80% increase in volume 
between 2002 and 2005, and the U.S. EPA 
has obscured the categories of the products 
in which each chemical is used (U.S. EPA 
2009). The TSCA inventory now lists about 
83,000 substances that have been for sale 
in the United States at some point since the 
inventory was first published in 1979 (U.S. 
EPA 2008a). Of these, approximately 62,000 
were in commercial use at the time TSCA 
was passed in 1976, and about 20,000 new 
substances have entered commercial use since 
that time (U.S. GAO 2005a).
Global chemical production is pro-
jected to continue growing—about 3% per 
year, with a doubling rate of 24 years, rap-
idly outpacing the rate of global population 
growth (Figure 2) [American Chemistry 
Council 2003; Organisation for Economic 
Cooperation and Development (OECD) 
2001; United Nations 2004]. This growth 
will distribute globally both the benefits and 
the health and environmental consequences 
of industrial chemical technologies. 
Human and environmental health conse-
quences. Bioaccumulative chemicals. Because 
of their wide distribution throughout the 
economy and environment, many industrial 
chemicals come in contact with people: in 
the workplace, in homes, through the use of 
products, and via air, water, food, and waste 
streams. Ultimately, at some point in their life 
cycle, all industrial chemicals will enter the 
earth’s ecosystems. Biomonitoring studies are 
demonstrating widespread human exposure 
to certain industrial chemicals and pollutants. 
In 2001‒2002, the U.S. Centers for Disease 
Control and Prevention (CDC) looked for, 
and found, 148 synthetic chemicals and pol-
lutants in the blood and urine of a represen-
tative sample of the U.S. civilian population 
(CDC 2005). The 2008 assessment is antici-
pated to include testing for about 250 sub-
stances for participants in the 2003‒2004 
National Health and Nutrition Examination 
Survey period.
Early life exposures. Evidence that many 
xenobiotic chemicals pass through the pla-
centa, entering and, in some cases, accumu-
lating in the fetus, suggests they could pose 
significant risks to human development (Barr 
et al. 2007; Doucet et al. 2008; Grandjean 
et al. 2007). Rising incidence of some cancers, 
asthma, and developmental disorders may be 
due in part to chemical exposures, particularly 
those that occur during development (Hertz-
Picciotto and Delwiche 2009; Sharpe and 
Irvine 2004; Surveillance, Epidemiology, and 
Figure 1. The three gaps in U.S. chemicals policy. Policy measures that address the gaps will promote sus-
tainable innovation in the chemical enterprise while improving human health and the environment.
Data gap
Producers are not required to
investigate and disclose sufﬁcient
information on the hazard traits of
chemicals or products to government,
downstream businesses that use
chemicals, or the public.
Safety gap
Government lacks the legal tools it
needs to efﬁciently identify,
prioritize, and take action to
mitigate the potential health and
environmental effects of hazardous
chemicals.
Technology gap
Industry and government have invested
only minimally in green chemistry
research, development, and education.
Chemicals policy
opportunity
The three gaps contribute to
a skewed market, which, if
corrected, will lead to new
investment by industry and
government in green
chemistry.
Figure 2. Global chemical production is projected to grow at a rate of 3% per year, rapidly outpacing the 
rate of global population growth, estimated at 0.77% per year. On this trajectory, chemical production will 
double by 2024, indexed to 2000 (American Chemistry Council 2003; OECD 2001; United Nations 2004).
500
400
300
200
100
0
P
r
o
j
e
c
t
e
d
 
g
r
o
w
t
h
 
i
n
d
e
x
2000 2005 2010 2020 2025
Year
2030 2040 2045 2050 2035 2015
Global chemical production
Global populationWilson and Schwarzman
1204  v o l u m e  117 | n u m b e r 8 | August 2009  •  Environmental Health Perspectives
End Results Program 2008). A variety of male 
reproductive abnormalities may also be linked 
to prenatal exposures to certain pesticides or 
endocrine-disrupting chemicals (Bay et al. 
2006; Main et al. 2006; Skakkebaek 2002; 
Swan et al. 2000, 2005). The data gap limits 
investigators’ ability to establish these links, 
and TSCA has all but prevented the U.S. EPA 
from instituting more than voluntary meas-
ures to act on these early indicators of harm. 
In assessing the state of the science, the Faroes 
Statement of the International Conference 
on Fetal Programming and Developmental 
Toxicity concluded that efforts to prevent 
exposures to hazardous chemicals should 
focus on protecting the embryo, fetus, and 
small child as highly vulnerable populations. 
The United States, however, lacks both the 
information and the regulatory mechanisms 
necessary to accomplish this goal (Grandjean 
et al. 2007). 
Occupational disease. Workers are 
at particular risk from chemical exposures 
because, depending on their occupation, they 
can be more highly exposed to hazardous 
substances than the general public (LaDou 
1997). Although the burden of all-cause 
occupational disease is enormous, resulting 
in over 60,000 deaths annually (Leigh et al. 
1997) national estimates of the proportion 
specifically attributable to chemical expo-
sures have not yet been compiled (Herbert 
and Landrigan 2000). Occupational disease 
reporting is generally suspected to under-
estimate true disease rates, given both the 
underdiagnosis of, and difficulty of account-
ing for, noninjury work-related illnesses 
(Herbert and Landrigan 2000). Immigrants, 
minorities, and lower-income communities 
typically bear a disproportionate burden of 
occupational chemical exposures and associ-
ated diseases (California EPA 2004; Pastor 
et al. 2002; Robinson 1991).
Occupational health data are more readily 
available in Europe. During the development 
of REACH, European Union research on 
potential occupational health benefits afforded 
by the regulation projected that the improved 
safety of workplace chemicals could prevent 
up to 40,000 cases of asthma annually (50% 
of occupationally related cases), an equal 
number of dermatitis cases, and 10,000 cases 
of COPD each year (Pickvance et al. 2005). 
The European Commission further estimated 
that REACH would prevent about 4,300 
occupational cancers per year. In all, the com-
mission estimated that the REACH regula-
tion would save €50 billion ($60 billion) over 
a 30-year period in total occupational disease 
prevention (European Commission 2003).
Hazardous waste. The management and 
cleanup of hazardous waste is another exter-
nalized cost largely attributable to existing 
chemical technology choices. Each year, the 
United States spends more than $1 billion 
managing Superfund sites, and future costs 
are estimated at $250 billion (U.S. EPA 
2007; U.S. GAO 2005b). On the current 
trajectory, the U.S. EPA anticipates the need 
for 217,000 new hazardous waste sites over 
the next 20 years (U.S. EPA 2004, 2007). 
This “end-of-pipe” approach to hazardous 
waste management can fail. In California, 
70% of legacy sites are leaking directly into 
ground  water, having breached their contain-
ment, and are now posing what the state’s 
Department of Toxic Substances Control 
(2007) calls a major threat to human health 
or the environment. That half of the most 
prevalent chemicals at existing sites are known 
teratogens, neurotoxicants, and/or carcinogens 
raises serious concerns for the health of resi-
dents in communities surrounding these sites 
(Agency for Toxic Substances and Disease 
Registry 2003; Ostrowski et al. 1999).
Toward a new chemicals policy. The cases 
noted above illustrate the expanding health 
and environmental problems attributable 
to an antiquated U.S. chemicals policy that 
has failed to keep pace with developments in 
either green chemistry or the environmental 
health sciences. Given the size of the chemi-
cal enterprise, the extent to which it is woven 
into the fabric of society, and the backlog 
of unexamined chemicals, a new approach 
is needed that does not rely on resource-
intensive, chemical-by-chemical risk assess-
ments in which government, at great public 
expense, bears the burden of proof. An inte-
grated chemicals policy is needed that enables 
identification and prioritization of chemicals 
of concern and employs market and regula-
tory tools sufficient to motivate investment by 
industry in the design and production of safer 
chemicals and materials, based on the princi-
ples of green chemistry. Making this transition 
will require a chemicals policy that departs 
markedly from the federal policies of the last 
30 years, of which TSCA is emblematic.
The link to green chemistry. The prin-
ciples of green chemistry offer an upstream 
solution to many of the health, environ-
mental, and economic problems related to 
industrial chemicals (Anastas and Warner 
1998; DeVito and Garret 1998; Lancaster 
2002; Lempert et al. 2003; NRC 2005). 
Implementation of these principles is criti-
cal if the chemical enterprise is to achieve 
sustainability. Specifically, green chemistry 
products are designed to be inherently less 
toxic and more readily broken down in the 
environment. Green chemistry processes use 
safer materials, operate more efficiently, and 
produce much less hazardous waste. 
To date, producers have not invested in 
green chemistry at a level commensurate with 
the scale and pace of chemical production 
(Cone 2008a, 2008b; Iles 2006; LaMonica 
2007; Lempert et al. 2003; NRC 2005). This 
is, to a large extent, a consequence of the U.S. 
chemicals market, which has been shaped 
over the last 30 years by the combined effects 
of the data, safety, and technology gaps. The 
European Union, meanwhile, has built a case 
for green chemistry in the European mar-
ket (Black 2008; Henzelmann et al. 2007), 
raising the twin specters of the U.S. chemi-
cals industry lagging behind its European 
counterpart in green chemistry innovation, 
and the United States becoming a market for 
hazardous chemicals and products that are 
prohibited for sale in the European Union 
and elsewhere (Cone 2006; Energy & Enviro 
Finland 2008). 
The laws governing the chemical enter-
prise help define the incentives and disincen-
tives that guide economic behavior in the 
market (Guth 2008). We use the term green 
chemistry in this context: as an analytical 
framework that encompasses both the sci-
ence of safer chemistry and the laws and poli-
cies that will motivate its development and 
adoption by society. Although there are a 
variety of financial, technical, organizational, 
and cultural barriers to the widespread adop-
tion of green chemistry practices by industry 
(Matus et al. 2007), addressing these barriers 
alone will not be sufficient to transform the 
chemical enterprise. Removing these barriers 
will require policy and regulatory reforms 
to improve the structure of incentives in the 
chemicals market.
Mapping the Policy Gaps
Of the federal environmental statutes, TSCA 
is the only U.S. law intended to enable regu-
lation of industrial chemicals both before 
and after they enter commerce. Other federal 
laws that pertain to chemicals are essentially 
“end-of-pipe” statutes that aim to control 
chemical emissions and exposures but do 
not permit premarket review of chemicals. 
Whereas TSCA potentially applies to some 
83,000 chemical compounds, five other 
major U.S. statutes combined currently 
apply to only 1,134 chemicals and pollutants 
(Dernbach 1997) (Table 1). 
Table 1. Numbers of industrial chemicals and pol-
lutants governed by U.S. law, excluding TSCA.
Federal statute  No. of substances
Clean Water Act (1966)  148
Resource Conservation and   502
  Recovery Act (1976)
Clean Air Act (1963)  189
Occupational Safety and   453
  Health Act (1970)
Emergency Planning and   600
  Community Right-to-Know Act; 
  Toxics Release Inventory (1986)
Although TSCA applies to tens of thousands of substances, 
only 1,134 chemicals and pollutants are listed under five 
major federal statutes (with overlap) (Dernbach 1997). Toward a new U.S. chemicals policy
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TSCA was the U.S. response to condi-
tions in which, before 1976, tens of thousands 
of chemicals entered markets without any 
form of accountability or oversight (Goldman 
2002). Congress articulated the statute’s 
objectives in TSCA §2 (TSCA 1976): 
•	Chemical	producers	should	develop	adequate	
data on the health and environmental effects 
of chemical substances and mixtures.
•	Government	should	have	adequate	author-
ity to regulate chemical substances that pres-
ent an unreasonable risk to health or the 
environ  ment, and to take action on immi-
nent hazards.
•	The	government’s	authority	over	chemi-
cal substances should not create unneces-
sary economic barriers to technological 
  innovation.
Based on these goals, TSCA promised to 
be an important step forward in the regula-
tion of industrial chemicals. In practice, how-
ever, its legal and procedural requirements 
have largely thwarted these objectives. 
The Data Gap
Logical paralysis. When it was passed in 1976, 
TSCA grandfathered the 62,000 chemical 
substances that were in commercial circula-
tion at that time; that is, except on a case-
by-case basis, chemical producers were not 
required to generate and disclose any informa-
tion about the uses or hazard traits of these 
products (U.S. GAO 1994). In essence, this 
body of existing chemicals was assumed to be 
safe unless the EPA could prove otherwise. To 
gather the necessary hazard and exposure data 
from producers, however, TSCA §4 required 
the U.S. EPA to establish, on a chemical-by-
chemical basis, a) that a substance may present 
an unreasonable risk to human health or the 
environment, or b) that there is either sig-
nificant human exposure potential or substan-
tial quantities of the chemical are produced, 
imported, and released into the environment 
(TSCA 1976). This created a logical paraly-
sis for the U.S. EPA: To systematically assess 
risks of existing chemicals, the EPA needed 
hazard and exposure data that producers were 
under no obligation to provide, unless the 
EPA could first show that such an unreason-
able risk might in fact exist or that high expo-
sures were already occurring. This has proved 
all but paralyzing for the U.S. EPA. In the first 
15 years under TSCA, the agency was able to 
review the risks of about 1,200 (2%) of the 
62,000 existing chemicals, despite the fact that 
the agency estimated that about 16,000 (26%) 
were potentially of concern based on their pro-
duction volume and chemical properties (U.S. 
GAO 1994).  TSCA §8(e) does require that 
chemical manufacturers, processors, and dis-
tributors notify the U.S. EPA of any new or 
unpublished chemical hazard information, and 
the EPA receives about 300 such submissions 
each year (U.S. EPA 2003). Perversely, how-
ever, this requirement creates a disincentive 
for manufacturers to voluntarily investigate 
the hazard properties of their products.
Existing chemicals. Although the TSCA 
inventory has grown to about 83,000 sub-
stances, the body of 62,000 existing chemi-
cals still constitutes nearly all chemicals in 
commercial use in the United States. In the 
2002 reporting year, 3,000 high production 
volume (HPV) chemicals—those produced 
or imported at more than one million pounds 
per year—made up > 99% by volume of the 
15 trillion pounds of chemicals in commerce. 
Although these HPV chemicals constitute 
only one-third of existing chemicals by count, 
their high volume raises concern about the 
lack of basic hazard information on existing 
chemicals. Although the U.S. EPA’s New 
Chemical Program requires some minimal 
data on chemicals introduced since 1976, 
these chemicals make up < 1% of the produc-
tion volume of the substances under the juris-
diction of TSCA (U.S. EPA 2005). 
In tacit acknowledgement of its con-
straints, the EPA has turned to voluntary 
initiatives to close the data gap on existing 
chemicals. The HPV Challenge (U.S. EPA 
2008b) is one such effort, begun in 1997 as 
an effort to gather screening-level data on 
HPV chemicals. It has been substantially lim-
ited, however, by late, incomplete, and poor- 
quality data submissions by chemical pro-
ducers (Denison 2007; Denison and Florini 
2004). In 2008, the U.S. EPA announced 
the Chemical Assessment and Management 
Program, in which the agency plans to con-
duct risk-based prioritizations for about 6,750 
chemicals (U.S. EPA 2008a). These assess-
ments, however, rely on incomplete data and 
information from TSCA inventory updates, 
much of which is obscured by trade secret 
claims and a lack of transparent assessment 
methods (Denison 2008).
The Safety Gap
Barriers to action. Given that the U.S. EPA 
bears the burden of proof, the agency is fur-
ther constrained by the level of evidence 
required to take regulatory action. To regu-
late a chemical, TSCA §6 requires the U.S. 
EPA to provide substantial evidence of all of 
the following conditions: The chemical pres-
ents or will present an unreasonable risk to 
health and the environment; the benefits of 
regulation outweigh both the costs to indus-
try of the regulation and the lost economic 
and social value of the product; the U.S. EPA 
has chosen the least burdensome means of 
addressing the source of unreasonable risk; 
and that no other statute could adequately 
address the risk (TSCA 1976). 
Under this evidentiary burden, the U.S. 
EPA has been able, since 1976, to use its 
formal rule-making authority to partially 
regulate five existing chemicals (or chemical 
classes): polychlorinated biphenyls (PCBs), 
chlorofluoro  carbons, dioxins, asbestos, and 
hexavalent chromium (U.S. GAO 1994). Of 
these, an amendment by Congress to TSCA 
required regulation of PCBs, and the U.S. 
EPA’s asbestos regulation, promulgated after 
the agency spent 10 years building its case, 
was overturned in its most significant aspects 
by the 5th Circuit Court of Appeals, which 
concluded that the U.S. EPA had failed 
to meet its burdens of proof under TSCA 
(Goldman 2002). 
New chemicals. TSCA does grant the U.S. 
EPA relatively more authority to regulate new 
chemicals introduced since 1976, as well as 
new uses of existing chemicals. Producers 
must submit premanufacturing notices 
(PMNs) before marketing a new chemical. 
However, there is no required minimum data 
set beyond information already in the pos-
session of the producer at the time they file 
the PMN. This has created a disincentive for 
manufacturers to investigate their products’ 
potential hazards because, although known 
hazards must be reported, ignorance of hazard 
is not penalized. Not surprisingly, an EPA 
evaluation found that 85% of PMNs lacked 
data on chemicals’ health effects, and 67% 
lacked health or environmental data of any 
kind (U.S. EPA 2003). Hindered by limited 
data and the short time period permitted for 
the agency’s review, the U.S. EPA has taken 
some form of action on < 10% of the 36,600 
chemicals that producers have proposed for 
commercial use between 1979 and 2004 
(U.S. EPA 2007). Once new chemicals have 
entered commercial use, the U.S. EPA may 
regulate them only under the standards and 
burdens it carries for existing chemicals, as 
described above.
Trade secrets. Extensive trade secret 
claims permitted under TSCA have exacer-
bated both the data and safety gaps. Although 
some protection of proprietary information 
is necessary, in practice the statute’s allow-
ances for confidential business information 
(CBI) claims have severely limited access to 
basic information on chemical identity and 
use. In 2005, the U.S. EPA reported that 
95% of PMNs submitted by producers con-
tained some information claimed as confi-
dential (U.S. GAO 2005a). One assessment 
found that 90% of the CBI claims in PMNs 
hid the identity of the chemical (U.S. EPA 
2003). CBI allowances under TSCA have 
thus contributed to a pervasive lack of supply-
chain transparency about chemical hazards, 
despite other regulations intended to facilitate 
hazard communication via Material Safety 
Data Sheets (Sattler et al. 1997; Occupational 
Safety and Health Administration 2004; U.S. 
Government Accountability Office 1991).Wilson and Schwarzman
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The Technology Gap
Minimal investment. By requiring less hazard 
information for existing substances than for 
new chemicals (data gap) and by stymieing 
effective regulation of well-known hazards 
(safety gap), TSCA has produced a chemicals 
market that favors existing chemicals over 
newer and potentially less toxic substances. As 
a result, the statute provides little motivation 
for industry investment in green chemis  try 
research and development. The vast major-
ity of chemical products manufactured in 
the United States rely on technologies devel-
oped 40‒50 years ago, a fact that led the 
Council for Chemical Research to call for 
new technologies that incorporate economi-
cal and environmentally safer processes, use 
less energy, and produce fewer harmful by-
products (Council for Chemical Research 
1996). Twelve years after the Council’s Vision 
2020 report, the Web sites of the 50 largest 
U.S. chemical companies all state their com-
mitment to reaching sustainability goals, but 
their spending on research and development 
has remained level or declined since about 
2000 (Lempert et al. 2003; NRC 2005). A 
National Research Council report concluded 
that this trend makes it difficult to advance 
the science and technology needed to support 
such sustainability goals (NRC 2005). 
Public investment is also critical to the 
development of green chemistry. The U.S. 
experience in other sectors illustrates that 
investment by government, federal labora-
tories, and research universities helps spur 
innovation of new technologies (Block and 
Keller 2008).
Education and the market. It is a reflection 
of the priorities of the U.S. chemicals market 
that, with rare exception, students can earn an 
undergraduate or graduate degree in chemistry 
at universities throughout the United States 
without demonstrating an understanding of 
the principles of toxicology, ecotoxicology, or 
green chemistry (Cone 2008c; NRC 2007). 
Educational priorities have largely matched 
those of the chemicals market, such that the 
hazard traits of a substance, for example, are 
undervalued in the chemistry classroom rela-
tive to chemical function, price, and perfor-
mance. Without a policy strategy that will 
favor green chemistry in the market, and with-
out a corresponding research and educational 
effort, the United States risks lagging behind 
the European Union and other industrialized 
regions in the scientific and technical develop-
ment of green chemistry. 
Effects of the Three Gaps
The most striking implication of the data gap 
is that the U.S. EPA lacks the information it 
needs to identify potential threats to public 
health and the environment. Perhaps equally 
significantly, the data-poor market makes 
safer alternatives difficult to distinguish from 
hazardous chemicals, distorting market signals 
(Guth et al. 2007). Furthermore, chemical 
hazard information generated by producers is 
often asymmetrically distributed, with inad-
equate communication to the market. Given 
better information, many downstream busi-
nesses, as well as governments, consumers, 
and workers, would be better able to express 
a preference for safer chemicals and prod-
ucts. The ability to identify safer substances 
could potentially lower the business costs of 
handling hazardous substances, estimated at 
7‒10 times the purchase cost of the chemical 
(Chemical Strategies Partnershp 2004).  
The safety gap compounds these problems 
by allowing the commercial circulation of haz-
ardous substances. The high level of evidence 
TSCA requires of the U.S. EPA makes it dif-
ficult for the agency to act on information it 
does have and impose restrictions on chemical 
use. With the burden of proof on government, 
lack of information increases the likelihood 
that hazardous chemicals will not be regulated. 
Some have argued that what begins as a regu-
latory disincentive for producers to generate 
or disclose hazard information has become 
an incentive to create mis  leading informa-
tion that casts doubt on scientific evidence 
(Michaels 2008). Given the high evidentiary 
threshold, doubt, in and of itself, effectively 
impedes the agency’s ability to take action 
(Guth et al 2007). 
Finally, as a result of the incentives 
created by TSCA, chemical producers are 
ration  ally motivated to defend existing chem-
icals (Ashford 2000; Echikson 2006). Those 
invested in existing chemicals have a strong 
commercial interest in resisting policies that 
could improve market transparency and the 
commercial viability of safer substitutes, as 
evidenced by the efforts of the American 
Chemistry Council to influence REACH 
negotiations (Brown 2003; Loewenberg 
2006; U.S. House of Representatives 2004). 
Although large “sunk” investments in 
existing chemicals and processes could make 
it difficult to transform the industrial sys-
tem to one based on the principles of green 
chemistry, industry will have to make this 
transition if the United States is to meet the 
challenge of economic and environmental 
sustainability.
Closing the Gaps: Implications 
for the Environmental Health 
Sciences
The transition to a sustainable chemical enter-
prise in the United States will require a fun-
damental reform of TSCA that meets three 
overarching objectives:
•	Close	the	data	gap:	Provide	for	the	effec-
tive operation of the chemicals market by 
requiring that chemical producers generate, 
disclose, distribute, and effectively commu-
nicate sufficient information to stakeholders 
on the hazard properties of chemicals. 
•	Close	the	safety	gap:	Provide	government	
with the legal tools necessary to identify, 
prioritize, and take action to reduce chemi-
cal hazards and exposures. 
•	Close	the	technology	gap:	Build	capacity	in	
cleaner chemicals and processes by incorpo-
rating scientific, technical, legal, and policy-
related elements of green chemistry into the 
nation’s education and research infrastructure. 
Accomplishing these objectives will require 
both supply-side and demand-side strategies 
(Green Chemistry Initiative 2008). Supply-
side strategies address the technology gap. They 
are intended to improve the supply of the sci-
ence, technology, and commercial applications 
of green chemistry through advancements 
in education, research, and development. 
Demand-side strategies address the data and 
safety gaps, primarily through public policies 
to drive data generation and disclosure and to 
regulate known hazards, a combination that 
ultimately improves the structure of incentives 
in the chemicals market. Demand-side policies 
also include, for example, laws that extend the 
scope of producer responsibility to include the 
complete product life cycle.
The two approaches operate in tandem: 
Demand-side strategies provide the requi-
site drive for supply-side solutions by gener-
ating the market need for new science and 
technology. That is, demand stimulates the 
private and public investments necessary to 
advance green chemistry innovation. The 
importance of market demand as a driver for 
industrial innovation is well established in the 
environmental sector. A survey of the execu-
tives of 90 leading companies operating in 
13 European Union countries identified pub-
lic policy and market demand as the two most 
important factors necessary for motivating 
environmental innovation in their companies 
(Henzelmann et al. 2007). Recent reports by 
the U.S. GAO (2009) and the Environmental 
Defense Fund (Denison 2009) are among 
others that have called for policy changes to 
improve the incentive structure in the chemi-
cals market by, for example, strengthening the 
U.S. EPA’s authority to obtain chemical haz-
ard information from producers and shifting 
more of the burden to producers to demon-
strate the safety of their products.
Undertaking meaningful chemicals policy 
reform in the United States will engender new 
research questions that must be informed by 
the environmental health sciences. Through 
the lens of the three policy gaps, these ques-
tions include the following: 
The data gap
•	What	is	the	most	useful	and	attainable	
body of standardized hazard and exposure 
information that should be generated for Toward a new U.S. chemicals policy
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chemicals, and how should a chemical’s sales 
volume and inherent hazard traits drive the 
scope of data requirements? 
•	What	is	the	proper	role	of	producers	in	gen-
erating these data, and how can the credibil-
ity, standardization, and quality of these data 
be assured? 
•	In	what	ways	can	emerging	predictive	toxic-
ity testing and exposure methods be applied 
to meet these data needs? 
•	What	information	on	chemical	hazards,	
exposures, and uses if made publicly avail-
able would most effectively protect public 
and environmental health and motivate the 
development of safer alternatives? 
•	What	are	the	most	effective	means	of	com-
municating chemical hazard and exposure 
information to stakeholders, including 
product formulators, downstream busi-
nesses, communities, workers, consumers, 
and   government agencies? 
The safety gap
•	On	what	measures	of	hazard	and	exposure	
(such as environmental persistence, bioac-
cumulative potential, toxicity, or presence 
in consumer products) should chemicals be 
prioritized and safer alternatives defined? 
•	To	what	extent	(and	in	what	ways)	should	
producers carry the burden of proof of 
chemical safety? 
•	What	level	of	evidence	of	potential	harm	to	
health or the environment is sufficient to 
trigger government action? 
•	What	portfolio	of	actions	should	govern-
ment employ to efficiently address identified 
hazards? 
•	What	are	the	appropriate	bounds	of	producer	
responsibility over the life cycle of chemi-
cals and products, and what policies can best 
ensure producer responsibility within these 
bounds? 
The technology gap
•	How	can	developments	in	the	environmental	
health sciences (such as biomonitoring find-
ings or the science of endocrine-disrupting 
chemicals) best be communicated to the 
chemical enterprise so as to drive continuous 
improvement in chemical design? 
•	What	are	the	high-priority	chemicals	and	
processes that warrant publicly funded 
research into green chemistry alternatives? 
•	What	are	the	scientific,	technical,	and	practi-
cal barriers to implementing these alternatives, 
and how are these barriers best addressed? 
•	How	should	green	chemistry	inform	the	
development of next-generation environ-
mental technologies, such as alternative 
energy and building materials, to reduce 
their health and environmental impacts and 
improve their overall sustainability?
•	How	should	green	chemistry	education	be	
designed to better prepare scientists, engi-
neers, and decision makers to respond to the 
challenges of sustainability? 
Conclusion
Although some leading businesses have 
adopted green chemistry methods, the vast 
potential of green chemistry remains untapped. 
This primarily reflects the priorities of the U.S. 
chemicals market, in which chemi  cal safety is 
undervalued relative to function, price, and 
performance. Hazardous chemicals have thus 
remained competitive, despite the many costs 
society bears as a result of their production, 
use, and eventual disposal. These market con-
ditions are a consequence of the chemical data 
gap, safety gap, and technology gap that have 
grown out of weaknesses in the language and 
implementation of TSCA. A new U.S. chemi-
cals policy has the potential to address the 
societal costs—human, environmental, and 
economic—that have accompanied advance-
ments in the chemical enterprise.  
New chemical and product laws in the 
European Union have opened an opportunity 
for chemicals policy reform in the United 
States. A fundamental restructuring of TSCA 
will need to simultaneously correct the data, 
safety, and technology gaps using strategies 
that improve both the demand for and sup-
ply of green chemistry technologies. The 
attendant research questions demand engage-
ment from the environmental health sciences, 
and their solutions offer the possibility of 
improving human health and environmental 
protection while moving the United States 
to a position of global leadership in green 
chemis  try innovation.
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